Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?

Simran Gupta, MD, Ayan Sen, MD and Aman Verma, DO
Cleveland Clinic Journal of Medicine October 2023, 90 (10) 603-605; DOI: https://doi.org/10.3949/ccjm.90a.23040
Simran Gupta
Division of Infectious Disease, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Ayan Sen
Chair, Department of Critical Care Medicine, Mayo Clinic Arizona, Phoenix, AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aman Verma
Assistant Professor, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 90 no. 10 603-605
DOI 
https://doi.org/10.3949/ccjm.90a.23040
PubMed 
37783502

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online October 2, 2023.

Copyright & Usage 
Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Simran Gupta, MD⇑
  1. Division of Infectious Disease, Massachusetts General Hospital, Boston, MA
  1. Address:
    Simran Gupta, MD, Division of Infectious Disease, Massachusetts General Hospital. 55 Fruit Street, Boston, MA 02114; sgupta{at}mgh.harvard.edu
  1. Ayan Sen, MD
  1. Chair, Department of Critical Care Medicine, Mayo Clinic Arizona, Phoenix, AZ
  1. Aman Verma, DO
  1. Assistant Professor, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 90 (10)
Cleveland Clinic Journal of Medicine
Vol. 90, Issue 10
1 Oct 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
Simran Gupta, Ayan Sen, Aman Verma
Cleveland Clinic Journal of Medicine Oct 2023, 90 (10) 603-605; DOI: 10.3949/ccjm.90a.23040

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
Simran Gupta, Ayan Sen, Aman Verma
Cleveland Clinic Journal of Medicine Oct 2023, 90 (10) 603-605; DOI: 10.3949/ccjm.90a.23040
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • SEPTIC SHOCK
    • WHY ALL THE INTEREST IN MIDODRINE?
    • WHAT DO THE DATA SHOW?
    • THE BOTTOM LINE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

1-Minute Consult

  • My adult patient’s hypercholesterolemia is not responding to statins—what’s next?
  • Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Show more 1-Minute Consult

Critical-Care

  • What is the role for terlipressin in hepatorenal syndrome?
  • COVID-19: A management update
Show more Critical-Care

Infectious-Diseases

  • What is the role for terlipressin in hepatorenal syndrome?
  • COVID-19: A management update
  • vOka vaccine-associated disseminated varicella zoster
Show more Infectious-Diseases

Similar Articles

Subjects

  • Critical Care
  • Infectious Diseases

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire